Logo image of KNW

KNOW LABS INC (KNW) Stock Fundamental Analysis

NYSEARCA:KNW - NYSE Arca - US4992382022 - Common Stock - Currency: USD

3.33  -0.03 (-0.89%)

After market: 3.3 -0.03 (-0.9%)

Fundamental Rating

0

KNW gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of KNW have multiple concerns. KNW does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

KNW had negative earnings in the past year.
KNW had a negative operating cash flow in the past year.
In the past 5 years KNW always reported negative net income.
In the past 5 years KNW always reported negative operating cash flow.
KNW Yearly Net Income VS EBIT VS OCF VS FCFKNW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

With a Return On Assets value of -1751.72%, KNW is not doing good in the industry: 99.47% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -1751.72%
ROE N/A
ROIC N/A
ROA(3y)-196.65%
ROA(5y)N/A
ROE(3y)-930.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KNW Yearly ROA, ROE, ROICKNW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 -500 -1K -1.5K -2K

1.3 Margins

KNW does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KNW Yearly Profit, Operating, Gross MarginsKNW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -2K -4K -6K -8K -10K

More info and screens

0

2. Health

2.1 Basic Checks

KNW has more shares outstanding than it did 1 year ago.
KNW has a worse debt/assets ratio than last year.
KNW Yearly Shares OutstandingKNW Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
KNW Yearly Total Debt VS Total AssetsKNW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -271.41, we must say that KNW is in the distress zone and has some risk of bankruptcy.
KNW has a worse Altman-Z score (-271.41) than 98.40% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -271.41
ROIC/WACCN/A
WACCN/A
KNW Yearly LT Debt VS Equity VS FCFKNW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M -10M

2.3 Liquidity

A Current Ratio of 0.07 indicates that KNW may have some problems paying its short term obligations.
KNW has a worse Current ratio (0.07) than 97.86% of its industry peers.
A Quick Ratio of 0.07 indicates that KNW may have some problems paying its short term obligations.
KNW has a worse Quick ratio (0.07) than 97.86% of its industry peers.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
KNW Yearly Current Assets VS Current LiabilitesKNW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

KNW shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 52.76%, which is quite impressive.
The Revenue for KNW has decreased by -100.00% in the past year. This is quite bad
EPS 1Y (TTM)52.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.8%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 1.18% on average over the next years.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y25%
EPS Next 2Y8.56%
EPS Next 3Y1.18%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KNW Yearly Revenue VS EstimatesKNW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2022 2026 2M 4M 6M
KNW Yearly EPS VS EstimatesKNW Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -5 -10 -15 -20

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KNW. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KNW. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KNW Price Earnings VS Forward Price EarningsKNW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KNW Per share dataKNW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -2 -4 -6 -8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.56%
EPS Next 3Y1.18%

More info and screens

0

5. Dividend

5.1 Amount

KNW does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KNOW LABS INC

NYSEARCA:KNW (7/11/2025, 8:04:02 PM)

After market: 3.3 -0.03 (-0.9%)

3.33

-0.03 (-0.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-14 2025-05-14
Earnings (Next)08-12 2025-08-12
Inst Owners1.32%
Inst Owner Change0%
Ins Owners8.64%
Ins Owner Change1.29%
Market Cap24.98M
Analysts80
Price Target40.8 (1125.23%)
Short Float %13.33%
Short Ratio0.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-6.51
EYN/A
EPS(NY)-9.29
Fwd EYN/A
FCF(TTM)-1.2
FCFYN/A
OCF(TTM)-1.2
OCFYN/A
SpS0
BVpS-0.78
TBVpS-0.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1751.72%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-196.65%
ROA(5y)N/A
ROE(3y)-930.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 90.1%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z -271.41
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)147.16%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.8%
EPS Next Y25%
EPS Next 2Y8.56%
EPS Next 3Y1.18%
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y12.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-34.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-49.63%
OCF growth 3YN/A
OCF growth 5YN/A